SCHEMBL6258124

SCHEMBL6258124

N#Cc1c(N)nc2sc(C(N)=O)c(N)c2c1-c1ccncc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.79
HSP90AB1 P08238 1/20 0.69
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
ALDH1A1 P00352 7/20 0.57
NPSR1 Q6W5P4 3/20 0.57
HPGD P15428 2/20 0.57
MAPK1 P28482 1/20 0.57
MAPT P10636 4/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GSK3B P49841 4/20 0.48
EEF2K O00418 2/20 0.46
USP2 O75604 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
HTT P42858 2/20 0.46
LMNA P02545 1/20 0.46
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
KDM4E B2RXH2 2/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1775711 0.89 BRAF (0.81) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL1776085 0.88 BRAF (1.00) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6257937 0.88 BRAF (0.83) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6254816 0.87 BRAF (0.81) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL12873679 0.87 BRAF (0.81) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6255310 0.87 BRAF (0.74) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6252961 0.87 BRAF (0.70) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6254867 0.86 BRAF (0.80) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL12873685 0.85 BRAF (0.78) BRAFHSP90AB1MEN1KMT2AALDH1A1
SCHEMBL6259467 0.83 BRAF (0.74) BRAFHSP90AB1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005058315-A1 NOVEL HETEROCYCLIC COMPOUNDS AS IKK2 INHIBITORS WITH ANTI-HBV ACTIVITY RIBAPHARM, INC. (US) 2005-06-30 WO disclosed